{
    "nctId": "NCT00912938",
    "briefTitle": "Evaluate the Relationship of Bone Remodeling Markers for Skeletal Complications in Metastatic Breast Cancer Patients",
    "officialTitle": "A Phase IV, Multi-center, Open Label, Single Arm Clinical Trial to Evaluate the Relationship of Bone Remodeling Markers for Skeletal Complications in Metastatic Breast Cancer Patients",
    "overallStatus": "UNKNOWN",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 237,
    "primaryOutcomeMeasure": "Urinary NTX and serum osteocalcin will be assessed at baseline, 3, 6, 9, and 12 months and when unexpected skeletal related events is detected.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patients with advanced breast cancer with radiographic confirmation of bone metastases (minimum of one bone scan lesion must be confirmed as metastatic on plain radiographs or CT/MR imaging)\n2. Men or women aged \u2265 18 years\n3. WHO (ECOG) performance status 0-2\n4. Women of child-bearing potential must be using a reliable and appropriate method of contraception\n5. Urine sample taken and sent to the central laboratory for baseline Ntx analysis\n6. Written informed consent.\n\nExclusion Criteria:\n\n1. Bisphosphonate treatment within the 4 weeks prior to planned first study treatment\n2. Abnormal renal function as evidenced by a calculated creatinine clearance \\< 30 ml/minute\n3. Poor venous access\n4. Metabolic bone disease\n5. Unable to comply with study procedures, especially the reliable collection of urine samples for bone resorption marker measurements\n6. Estimated life expectancy of \\< 6 months\n7. Treatment with systemic bone seeking radioisotopes within the 3 months prior to study entry\n8. Wide field (hemi-body) radiotherapy within the 3 months prior to study entry\n9. Concomitant medication with drugs known to affect bone metabolism\n10. Pregnancy or breast-feeding\n11. Current active dental problems including infection of the teeth or jawbone (maxilla or mandibular), or a current or prior diagnosis of osteonecrosis of the jaw (ONJ)\n12. Recent (within 4 weeks of study entry\\*) or planned dental or jaw surgery",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}